OSS Shares Ocean Sciences Ltd
ASX · ASXLast in our picks 2026-10-04 — not in the current list; analysis below is from that screen
Deep value optionality exists, but liquidity and risk profile limit investability.
Future value: $0.02 (+57.14%) · 6-12 months
Signal breakdown
- ▸Speculative upside, but very small-cap and less liquid.
- ▾Below 50-day MA (-8.62%)
- ▸Volume 4.03× average — accumulation
- ▸~57% upside to price target
Is OSS a buy right now?
Trend: OSS is trading above the 50-day average (+30.00%), RSI 5 — oversold territory, with a 3-month return of -35.00%.
Valuation & quality: fundamentals show net margin -50.5%, revenue growth 776.7% year on year.
Our screen: BUY (score 2) — Deep value optionality exists, but liquidity and risk profile limit investability.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -50.00% | +100.00% | -50.00% | +0.00% | +0.00% |
Fundamentals
Technical signals
About Ocean Sciences Ltd
Ocean Sciences Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes, and seaweeds.
Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.